Tag: Rajiv Nath
Budget 2024: AiMeD hails budget, calls it a boost to overall...
AiMeD Forum Coordinator Rajiv Nath says the medical devices industry was expecting more for quality and affordable healthcare
AiMeD & DRISP collaboration gives boost to Indo Russian medical device...
The experts from India and Russia stressed the need for a dynamic and multifaceted economic engagement at a recently held webinar
India gets a national policy on Pharma-MedTech R&D, Rs 5,000 Crore...
We need to transform Indian Pharma & MedTech sectors from a cost-based to a value-based & innovation-based industry, outlines Health Minister Dr Mansukh Mandaviya
HMD supplied 1.75 billion syringes for Covid-19 vaccination globally
Nearly 1 covid vaccine in every 7-8 people worldwide was administered using syringe manufactured by Hindustan Syringes & Medical Devices
AiMeD applauds govt’s latest MedTech policy decisions
These include National Medical Devices Policy 2023; Medical Devices Export Promotion Council; and Scheme for Assistance to Medical Devices Clusters for common facility
Industry lauds National Medical Devices Policy 2023 as a significant milestone
The leading associations and companies have welcomed the approval to the policy that outlines critical strategies such as regulatory simplification, infrastructure development, R&D, innovation facilitation and much more
India still remains 80% import dependent in medical devices
Industry veteran, Rajiv Nath takes us through the Indian medical devices market scenario during 2022 and the industry outlook for 2023
BioVoice eMagazine January 2023 Issue 1 Volume 4
Click to Read: January 2023 Edition of BioVoice eMagazine
BioVoice News, India's leading B2B news media for BioTech, HealthTech and AgriTech, is celebrating its 7th anniversary...
AiMeD urges PM for a separate department for medical devices
AiMeD on behalf of the Indian medical devices industry writes to PM Narendra Modi to change the name of Department of Pharmaceuticals to Department of Pharmaceuticals & Medical Devices
Local R&D & manufacturing, incentives critical to expansion of Indian MedTech...
Many experts call for a separate regulatory body for medical technology in the country whereas others feel that trade margin rationalization is important